GAS5 and coronary artery disorder: In contrast, the expression of lncRNA GAS5 in the plasma samples of CAD patients was reduced and its diagnostic potential was shown to be high, with an AUC of 0.9783 [89], thus suggesting that GAS5 lncRNA is a very promising biomarker for CAD.